Peripartum Pulmonary Embolism

Clinics in Chest Medicine

Volumn 32, Issue 1, 2011, Pages 147-164

  Miller, Margaret A ^a   Chalhoub, Michel ^b   Bourjeily, Ghada ^a  

^a BROWN UNIVERSITY   (United States)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

Heparin; Multidetector computed tomography pulmonary angiogram; Pregnancy; Pulmonary embolism; Venous thromboembolism; Ventilation perfusion scan

Indexed keywords

CONTRAST MEDIUM; COUMARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLOOD CLOT LYSIS; CLINICAL FEATURE; COMPRESSION GARMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG BIOAVAILABILITY; DRUG HALF LIFE; HUMAN; LABOR INDUCTION; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MATERNAL MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RADIATION EXPOSURE; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT PLANNING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; MATERNAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PULMONARY EMBOLISM; RISK FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 79251508339     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.11.005     Document Type: Review

References (135)

1. al-Meshari A., Chattopadhyay S.K., Younes B., et al. Trends in maternal mortality in Saudi Arabia. Int J Gynaecol Obstet 1996, 52:25-32.
2. Kobayashi T., Nakabayashi M., Ishikawa M., et al. Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan. Circ J 2008, 72:753-756.
3. Legnain M., Singh R., Busarira M.O. Maternal mortality in Benghazi: a clinicoepidemiological study. East Mediterr Health J 2000, 6:283-292.
4. Panting-Kemp A., Geller S.E., Nguyen T., et al. Maternal deaths in an urban perinatal network, 1992-1998. Am J Obstet Gynecol 2000, 183:1207-1212.
5. Sullivan E.A., Ford J.B., Chambers G., et al. Maternal mortality in Australia 1973-1996. Aust N Z J Obstet Gynaecol 2004, 44:452-457.
6. Andersen B.S., Steffensen F.H., Sorensen H.T., et al. The cumulative incidence of venous thromboembolism during pregnancy and puerperium-an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998, 77:170-173.
7. Gherman R.B., Goodwin T.M., Leung B., et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999, 94:730-734.
8. Heit J.A., Kobbervig C.E., James A.H., et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005, 143:697-706.
9. James A.H., Jamison M.G., Brancazio L.R., et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006, 194:1311-1315.
10. Lindqvist P., Dahlback B., Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999, 94:595-599.
11. Simpson E.L., Lawrenson R.A., Nightingale A.L., et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 2001, 108:56-60.
12. European perinatal health report by the Euro-Peristat project: [better statistics for better health for pregnant women and their babies]: data from 2004 Available at:, Accessed July 22, 2010. http://www.europeristat.com/index.shtml.
13. Danilenko-Dixon D.R., Heit J.A., Silverstein M.D., et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 2001, 184:104-110.
14. Jacobsen A.F., Skjeldestad F.E., Sandset P.M. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008, 6:905-912.
15. Treffers P.E., Huidekoper B.L., Weenink G.H., et al. Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 women. Int J Gynaecol Obstet 1983, 21:327-331.
16. McColl M.D., Ramsay J.E., Tait R.C., et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997, 78:1183-1188.
17. Bourjeily G., Paidas M., Khalil H., et al. Pulmonary embolism in pregnancy. Lancet 2010, 375:500-512.
18. Ray J.G., Chan W.S. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999, 54:265-271.
19. Greer I.A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005, 106:401-407.
20. Greer I.A. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999, 353:1258-1265.
21. James A.H., Tapson V.F., Goldhaber S.Z. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005, 193:216-219.
22. Bauersachs R.M., Manolopoulos K., Hoppe I., et al. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost 2007, 5:438-439.
23. Boer K., den Hollander I.A., Meijers J.C., et al. Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery. J Thromb Haemost 2007, 5:2415-2420.
24. Cumming A.M., Tait R.C., Fildes S., et al. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995, 90:725-727.
25. Greer I.A. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 2000, 342:424-425.
26. Hellgren M., Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981, 12:141-154.
27. Stirling Y., Woolf L., North W.R., et al. Haemostasis in normal pregnancy. Thromb Haemost 1984, 52:176-182.
28. Clark P., Brennand J., Conkie J.A., et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998, 79:1166-1170.
29. Rosenkranz A., Hiden M., Leschnik B., et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 2008, 99:331-337.
30. Comp P.C., Thurnau G.R., Welsh J., et al. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986, 68:881-885.
31. Kruithof E.K., Tran-Thang C., Gudinchet A., et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987, 69:460-466.
32. Ku D.H., Arkel Y.S., Paidas M.P., et al. Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 2003, 90:1074-1079.
33. Eliasson M., Evrin P.E., Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study. J Clin Epidemiol 1994, 47:513-524.
34. Ernst E., Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993, 118:956-963.
35. Landin K., Stigendal L., Eriksson E., et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990, 39:1044-1048.
36. Yarnell J.W., Sweetnam P.M., Rumley A., et al. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol 2000, 20:271-279.
37. Lee K.W., Lip G.Y. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003, 163:2368-2392.
38. Sanchez S.E., Zhang C., Rene Malinow M., et al. Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 2001, 153:474-480.
39. van Walraven C., Mamdani M., Cohn A., et al. Risk of subsequent thromboembolism for patients with pre-eclampsia. BMJ 2003, 326:791-792.
40. Wells P.S., Anderson D.R., Rodger M., et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000, 83:416-420.
41. Wells P.S., Anderson D.R., Rodger M., et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001, 135:98-107.
42. Carrier M., Wells P.S., Rodger M.A. Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: safety and clinical utility of 4 methods to assign pre-test probability. Thromb Res 2006, 117:469-474.
43. Panos R.J., Barish R.A., Whye D.W., et al. The electrocardiographic manifestations of pulmonary embolism. J Emerg Med 1988, 6:301-307.
44. Le Gal G., Righini M., Roy P.M., et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006, 144:165-171.
45. Powrie R.O., Larson L., Rosene-Montella K., et al. Alveolar-arterial oxygen gradient in acute pulmonary embolism in pregnancy. Am J Obstet Gynecol 1998, 178:394-396.
46. Roy P.M., Colombet I., Durieux P., et al. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005, 331:259.
47. van Belle A., Buller H.R., Huisman M.V., et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006, 295:172-179.
48. Kline J.A., Runyon M.S., Webb W.B., et al. Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients. Chest 2006, 129:1417-1423.
49. Perrier A., Roy P.M., Sanchez O., et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005, 352:1760-1768.
50. Morse M. Establishing a normal range for D-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis. J Thromb Haemost 2004, 2:1202-1204.
51. Eichinger S. D-dimer testing in pregnancy. Pathophysiol Haemost Thromb 2003, 33:327-329.
52. Chan W.S., Ray J.G., Murray S., et al. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 2002, 162:1170-1175.
53. Chan W.S., Chunilal S., Lee A., et al. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med 2007, 147:165-170.
54. Doshi S.K., Negus I.S., Oduko J.M. Fetal radiation dose from CT pulmonary angiography in late pregnancy: a phantom study. Br J Radiol 2008, 81:653-658.
55. Litmanovich D., Boiselle P.M., Bankier A.A., et al. Dose reduction in computed tomographic angiography of pregnant patients with suspected acute pulmonary embolism. J Comput Assist Tomogr 2009, 33:961-966.
56. Scarsbrook A.F., Bradley K.M., Gleeson F.V. Perfusion scintigraphy: diagnostic utility in pregnant women with suspected pulmonary embolic disease. Eur Radiol 2007, 17:2554-2560.
57. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990, 263:2753-2759.
58. Hurwitz L.M., Yoshizumi T., Reiman R.E., et al. Radiation dose to the fetus from body MDCT during early gestation. AJR Am J Roentgenol 2006, 186:871-876.
59. Winer-Muram H.T., Boone J.M., Brown H.L., et al. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology 2002, 224:487-492.
60. Groves A.M., Yates S.J., Win T., et al. CT pulmonary angiography versus ventilation-perfusion scintigraphy in pregnancy: implications from a UK survey of doctors' knowledge of radiation exposure. Radiology 2006, 240:765-770.
61. van Erkel A.R., van Rossum A.B., Bloem J.L., et al. Spiral CT angiography for suspected pulmonary embolism: a cost-effectiveness analysis. Radiology 1996, 201:29-36.
62. Doyle N.M., Ramirez M.M., Mastrobattista J.M., et al. Diagnosis of pulmonary embolism: a cost-effectiveness analysis. Am J Obstet Gynecol 2004, 191:1019-1023.
63. Moores L.K., Jackson W.L., Shorr A.F., et al. Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med 2004, 141:866-874.
64. Quiroz R., Kucher N., Zou K.H., et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA 2005, 293:2012-2017.
65. Stein P.D., Fowler S.E., Goodman L.R., et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006, 354:2317-2327.
66. Schaefer-Prokop C., Prokop M. CTPA for the diagnosis of acute pulmonary embolism during pregnancy. Eur Radiol 2008, 18:2705-2708.
67. Andreou A.K., Curtin J.J., Wilde S., et al. Does pregnancy affect vascular enhancement in patients undergoing CT pulmonary angiography?. Eur Radiol 2008, 18:2716-2722.
68. Khalil H., Bourjeily G., Lazarus E., et al. Multidetector CT pulmonary angiograms in pregnant patients: the "limited, no central PE" - how limited? 2007, Radiological Society of North America, Chicago.
69. Ridge C.A., McDermott S., Freyne B.J., et al. Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. AJR Am J Roentgenol 2009, 193:1223-1227.
70. U-King-Im J., Freeman S.J., Boylan T., et al. Quality of CT pulmonary angiography for suspected pulmonary embolus in pregnancy. Eur Radiol 2008, 18:2709-2715.
71. Schuster M.E., Fishman J.E., Copeland J.F., et al. Pulmonary embolism in pregnant patients: a survey of practices and policies for CT pulmonary angiography. AJR Am J Roentgenol 2003, 181:1495-1498.
72. Bourjeily G., Chalhoub M., Phornphutkul C., et al. Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero. Radiology 2010, 256(3):744-750.
73. Land C.E., Tokunaga M., Tokuoka S., et al. Early-onset breast cancer in A-bomb survivors. Lancet 1993, 342:237.
74. Tokunaga M., Land C.E., Tokuoka S., et al. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994, 138:209-223.
75. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2 2006, National Research Council (US) Committee to Assess Health Risks from Exposure to Low Level of Ionizing Radiation, National Academies Press, Washington, DC, Available at:, Accessed July 1, 2010. http://www.nap.edu/catalog/11340.html.
76. Einstein A.J., Henzlova M.J., Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 2007, 298:317-323.
77. Hopper K.D., King S.H., Lobell M.E., et al. The breast: in-plane x-ray protection during diagnostic thoracic CT-shielding with bismuth radioprotective garments. Radiology 1997, 205:853-858.
78. Parker M.S., Hui F.K., Camacho M.A., et al. Female breast radiation exposure during CT pulmonary angiography. AJR Am J Roentgenol 2005, 185:1228-1233.
79. Turkstra F., Kuijer P.M., van Beek E.J., et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1997, 126:775-781.
80. Torres J.A., Aracil E., Puras E., et al. Role of venous duplex imaging of lower extremity for pulmonary embolism diagnosis. Angiologia 1999, 51:71-76.
81. Mac Gillavry M.R., Sanson B.J., Buller H.R., et al. Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful?. Thromb Haemost 2000, 84:973-976.
82. Barrellier M.T., Lezin B., Landy S., et al. J Mal Vasc 2001, 26:23-30. [in French].
83. Stein P.D., Chenevert T.L., Fowler S.E., et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010, 152:434-443.
84. Marcos H.B., Semelka R.C., Worawattanakul S. Normal placenta: gadolinium-enhanced dynamic MR imaging. Radiology 1997, 205:493-496.
85. Hull R., Hirsh J., Sackett D.L., et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 1981, 64:622-625.
86. Garg K., Kemp J.L., Wojcik D., et al. Thromboembolic disease: comparison of combined CT pulmonary angiography and venography with bilateral leg sonography in 70 patients. AJR Am J Roentgenol 2000, 175:997-1001.
87. Loud P.A., Katz D.S., Bruce D.A., et al. Deep venous thrombosis with suspected pulmonary embolism: detection with combined CT venography and pulmonary angiography. Radiology 2001, 219:498-502.
88. Coche E.E., Hamoir X.L., Hammer F.D., et al. Using dual-detector helical CT angiography to detect deep venous thrombosis in patients with suspicion of pulmonary embolism: diagnostic value and additional findings. AJR Am J Roentgenol 2001, 176:1035-1039.
89. Garg K., Kemp J.L., Russ P.D., et al. Thromboembolic disease: variability of interobserver agreement in the interpretation of CT venography with CT pulmonary angiography. AJR Am J Roentgenol 2001, 176:1043-1047.
90. Rademaker J., Griesshaber V., Hidajat N., et al. Combined CT pulmonary angiography and venography for diagnosis of pulmonary embolism and deep vein thrombosis: radiation dose. J Thorac Imaging 2001, 16:297-299.
91. Scarsbrook A.F., Evans A.L., Owen A.R., et al. Diagnosis of suspected venous thromboembolic disease in pregnancy. Clin Radiol 2006, 61:1-12.
92. Ginsberg J.S., Wells P.S., Hirsh J., et al. Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. Arch Intern Med 1994, 154:1930-1933.
93. Heijboer H., Buller H.R., Lensing A.W., et al. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 1993, 329:1365-1369.
94. Hull R.D., Raskob G.E., Carter C.J. Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings. Ann Intern Med 1990, 112:663-667.
95. Wicki J., Perrier A., Perneger T.V., et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000, 84:548-552.
96. Aujesky D., Obrosky D.S., Stone R.A., et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005, 172:1041-1046.
97. Yoo H.H., De Paiva S.A., Silveira L.V., et al. Logistic regression analysis of potential prognostic factors for pulmonary thromboembolism. Chest 2003, 123:813-821.
98. Sukhija R., Aronow W.S., Lee J., et al. Association of right ventricular dysfunction with in-hospital mortality in patients with acute pulmonary embolism and reduction in mortality in patients with right ventricular dysfunction by pulmonary embolectomy. Am J Cardiol 2005, 95:695-696.
99. Binder L., Pieske B., Olschewski M., et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005, 112:1573-1579.
100. ten Wolde M., Sohne M., Quak E., et al. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 2004, 164:1685-1689.
101. Elkayam U., Gleicher N. Cardiac evaluation during pregnancy. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease 1998, 33-37. Wiley-Liss, New York (NY). 3rd edition. U. Elkayam, N. Gleicher (Eds.).
102. Goodman L.R. Small pulmonary emboli: what do we know?. Radiology 2005, 234:654-658.
103. Remy-Jardin M., Pistolesi M., Goodman L.R., et al. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology 2007, 245:315-329.
104. Couturaud F., Julian J.A., Kearon C. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis. Thromb Haemost 2001, 86:980-984.
105. Gould M.K., Dembitzer A.D., Doyle R.L., et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999, 130:800-809.
106. Dolovich L.R., Ginsberg J.S., Douketis J.D., et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 2000, 160:181-188.
107. Martel N., Lee J., Wells P.S. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005, 106:2710-2715.
108. Warkentin T.E., Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:311S-337S.
109. Pettila V., Leinonen P., Markkola A., et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002, 87:182-186.
110. Malcolm J.C., Keely E.J., Karovitch A.J., et al. Use of low molecular weight heparin in acute venous thromboembolic events in pregnancy. J Obstet Gynaecol Can 2002, 24:568-571.
111. Horlocker T.T., Wedel D.J., Rowlingson J.C., et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010, 35:64-101.
112. Casele H.L., Laifer S.A., Woelkers D.A., et al. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999, 181:1113-1117.
113. Hunt B.J., Doughty H.A., Majumdar G., et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997, 77:39-43.
114. Abou-Nassar K., Kovacs M.J., Kahn S.R., et al. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thromb Haemost 2007, 98:163-171.
115. Brieger D., Dawes J. Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments-comparison with unfractionated heparin. Thromb Haemost 1996, 75:740-746.
116. Hirsh J., Bauer K.A., Donati M.B., et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:141S-159S.
117. Chunilal S.D., Young E., Johnston M.A., et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002, 87:92-97.
118. Levine M.N., Hirsh J., Gent M., et al. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994, 154:49-56.
119. Leonhardt G., Gaul C., Nietsch H.H., et al. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006, 21:271-276.
120. Konstantinides S., Geibel A., Heusel G., et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002, 347:1143-1150.
121. Hall J.G., Pauli R.M., Wilson K.M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980, 68:122-140.
122. Prandoni P., Lensing A.W., Piccioli A., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002, 100:3484-3488.
123. Bates S.M., Greer I.A., Pabinger I., et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:844S-886S.
124. Jamjute P., Reed N., Hinwood D. Use of inferior vena cava filters in thromboembolic disease during labor: case report with a literature review. J Matern Fetal Neonatal Med 2006, 19:741-744.
125. Gates S., Brocklehurst P., Ayers S., et al. Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. Am J Obstet Gynecol 2004, 191:1296-1303.
126. Howell R., Fidler J., Letsky E., et al. The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial. Br J Obstet Gynaecol 1983, 90:1124-1128.
127. Brill-Edwards P., Ginsberg J.S., Gent M., et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy study group. N Engl J Med 2000, 343:1439-1444.
128. Pabinger I., Grafenhofer H., Kaider A., et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost 2005, 3:949-954.
129. De Stefano V., Martinelli I., Rossi E., et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol 2006, 135:386-391.
130. Robertson L., Wu O., Langhorne P., et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006, 132:171-196.
131. Dizon-Townson D., Miller C., Sibai B., et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005, 106:517-524.
132. Martinelli I., Legnani C., Bucciarelli P., et al. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001, 86:800-803.
133. Middeldorp S., Libourel E.J., Hamulyak K., et al. The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 2001, 113:553-555.
134. American College of Obstetricians and Gynecologists Practice Bulletin. Inherited thrombophilias in pregnancy. New York. Number 113, 2010.
135. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. London. Greep Top Guideline No. 37, 2009.